Precision Medicines

    OverviewSuggest Edit

    Precision Medicines is a clinical-stage biotechnology company. It focuses on in-licensing drug candidates for the treatment of various forms of cancer and then seeks to further develop these drug candidates for commercial use.
    HQMacclesfield, GB

    Latest Updates

    Employees (est.) (Feb 2020)4
    Cybersecurity ratingBMore
    Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
    Banner background

    Key People/Management at Precision Medicines

    Ansar Jawaid

    Ansar Jawaid

    Founder and Chief Executive Officer
    Ulf Jungnelius

    Ulf Jungnelius

    Chief Medical Officer
    Show more

    Precision Medicines Office Locations

    Precision Medicines has an office in Macclesfield
    Show all (1)

    Precision Medicines Online and Social Media Presence

    Embed Graph

    Precision Medicines News and Updates

    Ashvattha Therapeutics Announces $69 Million in Series B Financing and up to $45M Exclusive License Agreement with Huadong to Advance Hydroxyl Dendrimer-Based Precision Medicines

    – Series B Financing led by Huadong Medicine Investment Holding Co., Ltd, with participation from Natural Capital Investment Fund, Plum Alley Investments and Tribe Capital –

    Creyon Bio Launches to Engineer Safe, Effective Precision Medicines on Demand for All Patients

    SAN DIEGO and RESEARCH TRIANGLE PARK, N.C., March 8, 2022 /PRNewswire/ -- Creyon Bio, Inc. ("Creyon Bio"), a drug development company engineering RNA-based medicines and their components (oligonucleotide-based medicines or OBMs) with predictable safety and efficacy profiles, launched...

    RNA Transcriptomics Market Size to Reach USD 12.46 Billion in 2028 | Increasing Demand for Precision Medicines And Growing Investment are Major Factors Fueling Industry Growth, says Emergen Research

    Key players operating in the RNA Transcriptomics market are Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Agilent Technologies, Inc., Illumina, Inc., GenXPro GmbH, Fluidigm Corporation, CD Genomics, Sequentia Biotech SL, and Acobiom. Key players operating in the RNA Transcr…

    Precision Medicines Frequently Asked Questions

    • Who are Precision Medicines key executives?

      Precision Medicines's key executives are Ansar Jawaid and Ulf Jungnelius.

    • How many employees does Precision Medicines have?

      Precision Medicines has 4 employees.

    • Who are Precision Medicines competitors?

      Competitors of Precision Medicines include ImmunSYS, NOXXON Pharma and ASLAN Pharmaceuticals.

    • Where are Precision Medicines offices?

      Precision Medicines has an office in Macclesfield.

    • How many offices does Precision Medicines have?

      Precision Medicines has 1 office.